Mental Health Technology During the Era of COVID-19 by Tabet, Michael
University of Vermont 
ScholarWorks @ UVM 
Family Medicine Clerkship Student Projects Family Medicine Community 
2021 
Mental Health Technology During the Era of COVID-19 
Michael Tabet 
Follow this and additional works at: https://scholarworks.uvm.edu/fmclerk 
 Part of the Medical Education Commons, and the Primary Care Commons 
Recommended Citation 
Tabet, Michael, "Mental Health Technology During the Era of COVID-19" (2021). Family Medicine Clerkship 
Student Projects. 620. 
https://scholarworks.uvm.edu/fmclerk/620 
This Book is brought to you for free and open access by the Family Medicine Community at ScholarWorks @ UVM. 
It has been accepted for inclusion in Family Medicine Clerkship Student Projects by an authorized administrator of 
ScholarWorks @ UVM. For more information, please contact donna.omalley@uvm.edu. 
Mental Health Technology 
During the Era of COVID-19
Mike Tabet, MS3
CVPH Family Medicine
Rotation 6, Jan. 19 – Feb. 19, 2021
Mentor: Dr. Lindsey Wilhelm
What is the problem?
• COVID-19 pandemic has increased prevalence of depression and anxiety symptoms among U.S. adults, including among our own community
• Many factors:
• Drawn-out stay-at-home advisories, limitations on group gatherings, social isolation
• Economic uncertainty, job insecurities, increasing unemployment rates
• Anxiety -> reduced sleep/insomnia -> more anxiety
• Death of loved ones
• Diagnosis of COVID itself – 1/5 are diagnosed with a psychiatric disorder such as anxiety, depression, or insomnia within 14-90 days
• Lower income, having less than $5,000 in savings, and having exposure to more stressors were associated with a greater risk of depression 
symptoms
• Serious consideration of suicide among adults was reported to be 10.7% in June 2020, roughly twice the amount reported in all of 2018 (4.3%)
• Approximately 1 in 10 (13.3%) adults reported starting or increasing substance use to cope with stress or emotions related to COVID
Public Health Cost and Project Cost 
Considerations
• Public health cost
• Between 2005 and 2010, the economic burden of major depressive disorder (MDD) in the U.S. increased 
from $173.2 billion to $210.5 billion, a 21.5% increase
• For every $1.00 spent on direct costs of MDD (e.g., outpatient and inpatient services, pharmacy costs), $6.60 
was spent on comorbidities, workplace costs, and suicide-related costs
• Too early to tell the economic toll from COVID’s effect on mental health
• Cost consideration – free!*
*Headspace has a 7-day free trial, after which it is $12.99/month, or $95/year (~$8/month)
Community Perspective
1. What has the impact of COVID been on the 
mental health of your patients?
2. What aspect(s) of COVID have you noticed 
to play the biggest roles in COVID’s effect 
on the mental health of your patients?
3. What do you think has been particularly 
difficult about managing your patients’ 
mental health during COVID?
4. Have you noticed an associated increase in 
high-risk behaviors during this time?
5. Do you see a potential role for technology 
in helping patients manage their 
symptoms during this time?
6. Anything else?
• Anonymous, MD (Family Medicine, CVPH Family Medicine)
1. Increased depression and anxiety symptoms
2. Isolation, fear of getting sick (patients are “so scared” of getting COVID)
3. Prior to COVID, patients seemed to improve much better on pharmacotherapy. Now, increasing psych referrals 
due to refractory symptoms.
4. Increasing relapse rates on illicit substances
5. Not really. “The way I see it, people need personal interaction.”
6. Important to keep in mind that children are currently physically out of school. Many high-risk kids depend on 
early intervention programs (EIPs), which without them, might lead to a tougher time with social development 
and increased rates of mental health problems down the road.
• Anonymous, MD (Psychiatry, CVPH)
1. Obvious increase in depression and anxiety symptoms. “I can think of three of my patients off the bat who had 
been stable for a long time – at least two years – and became unstable in 2020. COVID was the only factor.”
2. Isolation, loss of employment, economic hardship, loss of structure in life
3. Not being able to see patients in person. Telemedicine is better than nothing, but it is not good enough from a 
psych perspective. There is a lack of ability to objectify a patient’s appearance and behavior, part of the mental 
status exam. This makes it truly difficult to comprehend the extent of a patient’s disease and effectively treat it.
4. A definite increase in substance use and relapse in patients with depression. Patients with anxiety have often 
decreased or avoided high-risk behaviors due to hypervigilance and overcaution around COVID.
5. Definitely, if the apps are evidence-based. Also important to keep in mind cost consideration. 
6. It has been especially difficult on psych consult service for mentally ill patients to not have visitors, and this 
might be contributing to worsening symptoms or lack of improvement of symptoms, leading to potentially 
longer stays.
Intervention and Methodology
• How can we help patients have access to certain evidence-based methods 
to address their mental health symptoms while away from their doctor’s 
office or counselor’s office?
• Smart devices have become increasingly ubiquitous in our society
• Recognize that apps exist that utilize evidence-based therapy techniques, 
making therapy portable and more accessible
• Intervention is simple: a handout listing and describing popular mental 
health apps that use research-based therapy strategies, in order to raise 




While apps alone cannot save lives, they can be a good mental health resource to go along with counseling and other treatments offered by 
your provider. If you are in urgent emotional distress, please call the National Suicide Prevention Lifeline at 1-800-273-8255 or NY Project 
Hope’s Emotional Support Helpline at 1-844-863-9314. Help is available.
Breathe2Relax: A simple, intuitive, and attractive mobile app designed by the National 
Center for Telehealth & Technology to teach breathing techniques to manage stress. The 
skills taught may be applied to those with anxiety disorders, stress, and PTSD.
MindShift: Targeted to help adolescents, teens, and young adults gain insight into and 
basic skills to manage their symptoms of anxiety disorders, including GAD, social anxiety, 
specific phobias, and panic attacks. It’s also useful for managing worry, performance anxiety, 
test anxiety, and perfectionism. The skills taught may be applied to individuals with physical, 
emotional, cognitive, or behavioral manifestations of anxiety, providing users with more 
helpful, balanced ways of thinking about feared situations.
MY3: Designed to help those stay safe while having thoughts of suicide, MY3 lets you 
customize your own personal safety plan by noting your warning signs, listing coping 
strategies, and connecting you to helpful resources to reach out to when you need 
them most. At your fingertips is a button that puts you in direct contact (24 hours a 
day, 7 days a week) with a trained counselor from the National Suicide Prevention 
Lifeline as well as a 911 alert. Additionally, you can choose three people to contact in 
the event you’re having thoughts of suicide.
Headspace: Targeted to anyone who wants to learn meditation to reduce anxiety and 
stress and improve their attention and awareness. The skills taught include mindfulness and 
cognitive diffusion, breathing exercises, meditation practice, tips for increased relaxation, 
concentration; may be applied to anxiety and depressive disorders, PTSD, and OCD.
CBT-i Coach: CBT-i Coach is for people who have experienced symptoms of insomnia and 
would like to improve their sleep habits. The app will guide users through the process of 
learning about sleep, developing positive sleep routines, and improving their sleep 
environments. It provides a structured program that teaches strategies proven to improve 
sleep and help alleviate symptoms of insomnia.
MoodTools: A self-help app targeting depression. It provides psychoeducation about risk 
factors and psychosocial approaches to treatment, a depression symptom questionnaire 
(PHQ-9), a thought diary, a suicide safety plan, and videos such as meditation guides.
Insight Timer: Offers courses on how to meditate, and an expansive free library of more 
than 35,000 guided meditations (including for sleep) with renowned meditation and 
mindfulness experts, neuroscientists, psychologists, and teachers from Stanford, Harvard, 
and more. It will also track your progress and streaks with charts.
Evaluation and Limitations
• Evaluate with:
• Prospective PHQ-9 and GAD-7 trends (possibly compare it to a control population of 
patients that did not utilize any apps)
• Follow-up survey that measures how many patients utilized at least one app, frequency of 
use, and whether they personally found them useful or not
• Opinions of providers on utility and effectiveness
• Limitations of project:
• Selection bias – only those patients with a desire for app use will likely accept the handout 
and try out the apps; also, generational gap may favor younger, more tech-savvy patients
• Lack of time for objective measure of baseline depression and anxiety among the 
population
• While all the recommended apps are basically free, Headspace – one of the most highly 
recommended and utilized mindfulness meditation apps – does have a fee after the first 
seven days, which might be a limiting factor in this population
Future Recommendations
• Positive responses from this cohort of patients could lead to more widespread utilization of 
app recommendations in clinics beyond Plattsburgh, as an extra tool in a patient’s arsenal; 
with more finetuning of the handout, have it UVMHN-certified so that it may be officially 
distributed to other UVMHN clinical sites
• Further stratify the patient population based on current treatment status (i.e., no 
treatment, pharmacotherapy, psychotherapy, etc.) and/or symptom severity
• Do the apps have a significantly positive effect on all patients with mental health symptoms, 
regardless of treatment status or symptom severity, or do they appear to only help those with worse 
symptoms and those already being treated by augmenting the effects of treatment?
• Look further into COVID-era prevalence of substance use disorder, relapse, and other high-
risk behaviors compared with the prevalence post-COVID and determine whether certain 
apps might play a therapeutic role – if no such apps exist, this might be a good opportunity 
for app-developers to create evidence-based apps to address these needs
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